Hep Email Update Nutrition and Exercise and Hepatitis C You can take a lot of steps to lessen the damage the virus may do to your liver. Advertisement Bulevirtide Continues to Show Promise for People With Hepatitis D The new drug reduced HDV viral load and lowered liver enzyme levels in people with hepatitis B and D. Ex-Moderna Exec Named President of the Baruch S. Blumberg Institute Randall N. Hyer, MD, PhD, will continue Blumberg Institute’s hepatitis B and liver cancer research in his new role as president. Exercise Alters Body Fat Metabolism of People With Fatty Liver Disease Even without weight loss, high-intensity exercise improved metabolism in people with NAFLD. Children With Liver Disease at Risk for Type 2 Diabetes Children with non-alcoholic fatty liver disease need to be closely observed to help combat type 2 diabetes later in life. The Hep Magazine Archives To read past issues of Hep, click the link! Advertisement Science News A Third of Pregnant People on Medicaid With Opioid Use Disorders Have Hepatitis C Bulevirtide Continues to Show Promise for People With Hepatitis D Mood and Cognition Improve After Hepatitis C Cure Immune Modulator Drugs Improved Survival for People Hospitalized With COVID-19 Newsfeed Ex-Moderna Exec Named President of the Baruch S. Blumberg Institute A Proposal in the Senate to Import Drugs From Other Countries Hospital Patient Data Secretly Sent to Facebook, Alleges Lawsuit Children With Liver Disease at Risk for Type 2 Diabetes Science News A Third of Pregnant People on Medicaid With Opioid Use Disorders Have Hepatitis C Bulevirtide Continues to Show Promise for People With Hepatitis D Mood and Cognition Improve After Hepatitis C Cure Immune Modulator Drugs Improved Survival for People Hospitalized With COVID-19 Newsfeed Ex-Moderna Exec Named President of the Baruch S. Blumberg Institute A Proposal in the Senate to Import Drugs From Other Countries Hospital Patient Data Secretly Sent to Facebook, Alleges Lawsuit Children With Liver Disease at Risk for Type 2 Diabetes

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@hepmag.com. Please remember to add update@hepmag.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: